Osprey Medical announces additional findings from AVERT clinical trial
Posted:
2015-12-18 in Press Releases
Auspherix Appoints Dr. Neil Miller as Chief Scientific Officer
Posted:
2015-12-01 in Press Releases
$9 Million Cash Injection for Two Victorian Biotech Companies
Posted:
2015-11-23 in Press Releases
Osprey Medical - AVERT Trial Results, Three FDA Expanded Claims Achieved-Full US Commercial Launch
Posted:
2015-10-19 in Press Releases
Osprey Medical Receives DyeVert™ System FDA Clearance
Posted:
2015-10-12 in Press Releases
Auspherix Expands Board of Directors and Scientific Advisory Board
Posted:
2015-07-24 in Press Releases
Verva Pharmaceuticals Signs Deals with Two Biotechs.
Posted:
2015-07-20 in Press Releases
Australian pain drug innovation comp. Spinifex Pharmaceuticals sold to Novartis for US$200m
Posted:
2015-06-29 in Press Releases
Auspherix Raises £6Million to Progress its Novel Antibiotics and Establishes UK Operations
Posted:
2015-06-03 in Press Releases
OccuRx launched with up to AU$6.5 M in funding
Posted:
2015-05-18 in Press Releases
Brandon Capital Partners Raises AU$200M New MRCF Fund
Posted:
2015-04-21 in Press Releases
Otifex Successfully Completes First Phase 1 Clinical Study
Posted:
2015-02-10 in Press Releases
Vaxxas Raises A$25 Million [US$20 Million] in Series B Venture Financing to Accelerate Commercializa
Posted:
2015-02-10 in Press Releases
Solvanix launched with start-up investment from the MRCF
Posted:
2015-01-15 in Press Releases